Emergency Medicine, Emergency Medical Services · Los Angeles, CA
NPI
1649402678
Since 2009
Specialty
Emergency Medicine, Emergency Medical Services
Code 207PE0004X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2400 S Flower St
Los Angeles, CA, 90007
Phone (213) 742-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$781K
16,481 services
Medicare patients, 2024
1,108
Average age 75
Drug cost, 2024
$1.9M
4,055 prescriptions
Company payments, 2025
$26.18
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tigran Avoian was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 5,709 times for 675 patients. In total Tigran Avoian billed 16,481 services in 119 codes, and Medicare paid $781K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-27.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 5,709 | 675 | $0.77 | $4,413 |
| J7324 Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | Office | 2,041 | 295 | $98.56 | $201K |
| 20611 Joint Injection | Office | 1,582 | 352 | $114.18 | $181K |
| 99214 Office E&M - Established | Office | 1,383 | 698 | $103.64 | $143K |
| 97140 PT Treatment | Office | 639 | 53 | $21.01 | $13K |
| 97035 PT Treatment | Office | 638 | 53 | $8.82 | $5,626 |
| 99204 Office E&M - New | Office | 578 | 578 | $127.67 | $74K |
| 73564 X-ray - Lower Extremity | Office | 547 | 288 | $42.30 | $23K |
| 20610 Joint Injection | Office | 503 | 314 | $53.09 | $27K |
| G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 415 | 53 | $7.42 | $3,078 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 283 | 65 | $0.53 | $150 |
| 73030 X-ray - Upper Extremity | Office | 255 | 197 | $30.00 | $7,651 |
| 73110 X-ray - Upper Extremity | Office | 214 | 87 | $35.10 | $7,512 |
| 73130 X-ray - Upper Extremity | Office | 212 | 136 | $32.83 | $6,960 |
| 72110 X-ray - Spine and Pelvis | Office | 187 | 184 | $43.44 | $8,123 |
By year: 2022 $641K for 33,645 services; 2023 $576K for 15,156 services; 2024 $781K for 16,481 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tigran Avoian prescribed most often to Medicare patients was Diclofenac Sodium, with 2,204 prescriptions and refills. In total Tigran Avoian wrote 4,055 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diclofenac Sodium Generic | 2,204 | 2,252 | 443 | $1.8M |
| Celecoxib Generic | 942 | 957 | 542 | $16K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 282 | 282 | 222 | $1,665 |
| Meloxicam Generic | 201 | 221 | 117 | $256 |
| Methylprednisolone Generic | 98 | 98 | 88 | $526 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 54 | 54 | 43 | $236 |
| Gabapentin Generic | 48 | 48 | 40 | $78.25 |
| Lidocaine Generic | 41 | 41 | Under 11 | $3,907 |
| Tramadol Hcl Generic | 40 | 41 | 21 | $64.95 |
| Ibuprofen Generic | 34 | 34 | 22 | $107 |
| Naproxen Generic | 24 | 24 | 23 | $76.53 |
| Meloxicam Meloxicam, Submicronized | 15 | 15 | Under 11 | $13K |
| Diclofenac Potassium Generic | 13 | 16 | Under 11 | $25K |
| Cyclobenzaprine Hcl Generic | 11 | 11 | 11 | $40.37 |
Brand drugs: - claims; generic drugs: 3,982 claims; opioid claims: 377.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tigran Avoian $26.18 ($26.18 in general payments such as food, travel and fees) from 1 company. The largest payer was Vertex Pharmaceuticals Incorporated with $26.18.
| Company | Payments | Amount |
|---|---|---|
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $26.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.